Gerostate Alpha
Mark is an expert in small molecule and genetic screens and has significant experience with high throughput technologies, and has utilized simple model organisms to explore pharmacological extension of lifespan.
Mark holds a Bachelor’s degree in Molecular, Cell and Developmental Biology from the University of California, Santa Cruz where he graduated with highest honors. He earned his PhD studying developmental neuroscience at the University of California, Davis. Mark previously held a research assistant professor position at the Buck Institute for Research on Aging.
This person is not in any offices
Gerostate Alpha
Gerostate Alpha is a new pharmaceutical company dedicated to treating aging and age-related disease.